- Home
- CBUS vs MYO Comparison
CBUS vs MYO Comparison
Compare CBUS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- MYO
- Stock Information
- Founded
- CBUS 2010
- MYO 2004
- Country
- CBUS United States
- MYO United States
- Employees
- CBUS N/A
- MYO N/A
- Industry
- CBUS Agricultural Chemicals
- MYO Industrial Specialties
- Sector
- CBUS Industrials
- MYO Health Care
- Exchange
- CBUS Nasdaq
- MYO Nasdaq
- Market Cap
- CBUS 127.1M
- MYO 113.3M
- IPO Year
- CBUS 2017
- MYO 2017
- Fundamental
- Price
- CBUS $4.78
- MYO $4.84
- Analyst Decision
- CBUS Strong Buy
- MYO Strong Buy
- Analyst Count
- CBUS 3
- MYO 4
- Target Price
- CBUS $22.83
- MYO $7.75
- AVG Volume (30 Days)
- CBUS 146.1K
- MYO 177.6K
- Earning Date
- CBUS 11-07-2024
- MYO 11-06-2024
- Dividend Yield
- CBUS N/A
- MYO N/A
- EPS Growth
- CBUS N/A
- MYO N/A
- EPS
- CBUS N/A
- MYO N/A
- Revenue
- CBUS $4,152,999.00
- MYO $25,239,125.00
- Revenue This Year
- CBUS $36.93
- MYO $53.19
- Revenue Next Year
- CBUS $236.45
- MYO $39.01
- P/E Ratio
- CBUS N/A
- MYO N/A
- Revenue Growth
- CBUS 449.34
- MYO 36.23
- 52 Week Low
- CBUS $2.86
- MYO $2.51
- 52 Week High
- CBUS $23.18
- MYO $5.64
- Technical
- Relative Strength Index (RSI)
- CBUS 58.32
- MYO 62.80
- Support Level
- CBUS $4.80
- MYO $4.65
- Resistance Level
- CBUS $6.10
- MYO $5.05
- Average True Range (ATR)
- CBUS 0.49
- MYO 0.32
- MACD
- CBUS 0.13
- MYO 0.10
- Stochastic Oscillator
- CBUS 51.35
- MYO 63.00
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).